We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Experts: Price Controls Unlikely Despite Recent Senate Push
Despite a Senate hearing Tuesday over the high price of HIV treatments, industry onlookers say any price controls on the drugs are unlikely in the near future.